| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/LARY.24296 |
| P698 | PubMed publication ID | 23832649 |
| P50 | author | Jason Zhu | Q61090351 |
| P2093 | author name string | Stacey Fedewa | |
| Amy Y Chen | |||
| P433 | issue | 1 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 131-138 | |
| P577 | publication date | 2013-08-05 | |
| P1433 | published in | The Laryngoscope | Q15755068 |
| P1476 | title | Temporal trends in oropharyngeal cancer treatment and survival: 1998-2009 | |
| P478 | volume | 124 |
| Q90454351 | A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer |
| Q47381216 | Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma. |
| Q35602115 | Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience |
| Q90734225 | De-escalation of post-treatment surveillance in oropharyngeal cancer |
| Q58792607 | Detection of Second Primary Malignancies of the Esophagus and Hypophraynx in Oral Squamous Cell Carcinoma Patients |
| Q31057384 | Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base |
| Q39376888 | Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study. |
| Q39002431 | Long-term survival outcomes in patients with surgically treated oropharyngeal cancer and defined human papilloma virus status |
| Q64273496 | Management of clinically N0 neck in oropharyngeal carcinoma |
| Q37134967 | Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines |
| Q39370399 | National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma |
| Q38242384 | Oncological and functional outcomes of transoral surgery for the treatment of oropharyngeal cancer |
| Q89273770 | Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity |
| Q54284032 | Role of primary surgery in the treatment of advanced oropharyngeal cancer. |
| Q48359652 | Salvage surgery for oropharyngeal squamous cell carcinomas: A retrospective study from 2005 to 2013. |
| Q90307793 | Socioeconomic disparities in a population of patients undergoing total thyroidectomy for benign disease |
| Q46469826 | Surrogate for oropharyngeal cancer HPV status in cancer database studies. |
| Q38757924 | Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches |
| Q47789789 | Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: A retrospective analysis |
| Q38194548 | Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib |
| Q40046174 | The Benefit of Adjuvant Radiation in Surgically-Treated T1-2 N1 Oropharyngeal Squamous Cell Carcinoma |
| Q64111443 | The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer |
| Q40647310 | Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey. |
| Q46771512 | Trends and variations in the use of adjuvant therapy for patients with head and neck cancer |
Search more.